Stephen J. Fanning
Chairman of the Board, President and Chief Executive Officer

Stephen J. Fanning was appointed President and Chief Executive Officer of Thermage, Inc. on January 15, 2005 and Chairman of the Board of Directors effective as of July 31, 2006. Mr. Fanning joined Thermage, Inc. from Ocular Sciences, Inc., a $350 million global public company, which developed, manufactured and marketed disposable contact lenses. Mr. Fanning had been President and Chief Executive Officer of the Company and a member of the Board of Directors since August 13, 2001. Under his leadership, Ocular Sciences implemented a next-generation manufacturing process significantly driving down the cost of goods sold, achieved significant increases in global market share and attained more than $300 million in annual sales. In January 2005, Ocular Sciences was successfully acquired by CooperVision for $1.3 billion. Mr. Fanning joined Ocular Sciences from Johnson & Johnson (J&J), one of the world's largest manufacturers of healthcare products, where he served in various senior executive positions of escalating responsibility for 25 years. His most recent position was President, Worldwide, of J&J's McNeil Specialty Products division. Prior to that, he served as President of Johnson & Johnson Medical, a medical device company. Mr. Fanning has also served as Managing Director of J&J Austria/Switzerland, and Vice President, Sales, of J&J's McNeil Consumer Products Division. Mr. Fanning holds a Bachelor of Science degree from Philadelphia University.

 

William E. Brodie
Vice President of U.S. Sales

Bill Brodie joined Thermage in February of 2006 as Director of Sales, Eastern US. Mr. Brodie was promoted to Vice President of Domestic Sales in January of 2008. He brings more than 17 years of sales management experience and business development in both the medical and dental markets. Most recently, he served as Vice President of Sales and Field Operations with Benco Dental Company, a leader in dental office equipment sales, office design and supply management. His responsibilities for this $300 million, privately-held company included leading a sales force of over 600 field personnel, as well as inside sales, international sales, and practice development consulting. From 1998 to 2002 he held various sales management positions with Benco. Prior to 1998 Mr. Brodie was the founder, president and owner of Quality Central Dental a dental sales company based in Orlando, FL until the 1998 merger with Benco. He holds a Master of Science in Management from Georgia Institute of Technology, and a Bachelor of Science from Rollins College.

 

Clint Carnell
Chief Operating Officer

Clint Carnell joined Thermage in September 2005 as Vice President of Domestic Sales. Mr. Carnell was appointed Chief Operating Officer in January 2008. Mr. Carnell brings 15 years of experience to Thermage in medical device sales, sales management and business development with both public and private companies. Most recently, he served as Vice President of US Surgical Sales with Bausch and Lomb where he oversaw the turnaround of a $215 million division of B&L, including responsibility for the cataract, refractive and vitreoretinal sales and support teams. Prior to 2000, Mr. Carnell held the role of Director of Corporate Development with Gambro Healthcare where he was responsible for the development of dialysis clinics and physician partnerships with nephrologists. Prior to Gambro, Mr. Carnell held various sales and sales management positions with companies such as Johnson & Johnson, Versyss Medical and in the financial software industry. Mr. Carnell was the founder and a board member of privately held Charleston Renal Care, recently sold to DaVita, Inc. Mr. Carnell holds a Bachelor of Arts from Duke University.

 

H. Daniel Ferrari
Vice President of Business and Financial Planning

Dan Ferrari joined Thermage in November 2004 and brings more than 20 years of financial management experience with both public and private companies including over 11 years in the medical device industry. From 2001 to 2004, Mr. Ferrari served as Vice President, Corporate Controller of Critical Path, Inc., a $70 million revenue publicly held enterprise software and hosted messaging company, where he rebuilt the financial organization, established strong financial controls, and managed restructuring of the company. From 1999 to 2001, Mr. Ferrari was a financial consultant for a number of private companies, advising executive management regarding business model optimization, mergers and acquisitions, funding strategy, the IPO process and other financial matters. Prior to consulting, Mr. Ferrari served as Vice President, Finance of ReSound, Inc. a publicly held hearing device company, and was with the company from 1994 through 1999. During his tenure at ReSound, Mr. Ferrari was a major contributor on several acquisitions, establishment of an offshore manufacturing facility, and a number of securities offerings as revenues grew from $35 million to over $125 million prior to sale of the company to GN Great Nordic. Mr. Ferrari holds a BS in Commerce and MBA from Santa Clara University.

 

John (Jack) Glenn
Chief Financial Officer

Jack Glenn joined Thermage in January 2008 as Chief Financial Officer, bringing with him almost 25 years of financial leadership experience with both private and publicly traded companies. He joins the Company from Cholestech, Inc., a publicly traded company providing diagnostic tools for the monitoring and assessment of heart disease, where he held the role of Chief Financial Officer and Vice President of Finance for three years before assisting in its strategic acquisition by Inverness Medical Innovations. Prior to Cholestech, Mr. Glenn held the role of Chief Financial Officer and Vice President of Finance for Invivo Corporation for 14 years. Invivo Corporation, a publicly traded medical device manufacturer, was sold to Intermagnetics in January of 2004. During Mr. Glenn's tenure at Invivo Corporation, he played a key role in the identification, negotiation and structuring of four successful acquisitions, two secondary public equity offerings and two divestitures of non-strategic businesses. Mr. Glenn holds a BS in business administration from the University of Nevada and an MBA from Santa Clara University.

 

Doug W. Heigel
Vice President of Operations

Doug Heigel joined Thermage in May of 2002 as Senior Director of Operations and in July of 2003 he was promoted to the position of Vice President of Operations. He has more than 20 years of management experience involving engineering, manufacturing, supply chain management and product service related to scientific instrumentation, capital equipment and related consumables. From 1995 until 2002, Mr. Heigel was Vice President of Manufacturing for Argonaut Technologies, a manufacturer of automated synthesis equipment and chemistry consumables utilized in pharmaceutical and biotech drug discovery research. Mr. Heigel developed Argonaut's instrument manufacturing capability and introduced several successful instrument product lines that propelled Argonaut through a successful IPO in 2000. From 1988 to 1995 Mr. Heigel held Engineering and Operations Management positions at Microsensor Technology, a manufacturer of innovative, portable gas analyzers that was acquired by Agilent Technologies. Mr. Heigel earned his BS in Mechanical Engineering from Oregon State University.

 

Cherry Hu
Vice President, Principal Accounting Officer and Corporate Controller

Cherry Hu joined Thermage in July 2006 as Thermage’s Corporate Controller and was promoted to Vice President, Principal Accounting Officer and Corporate Controller in January 2008. She has more than 20 years of experience in financial management and control with both public and private companies. From October 2003 to January 2006, she was Corporate Controller at Fortinet, Inc., a privately held network security company. Prior to Fortinet, Ms. Hu spent 16 years with 3Com Corporation, a global high tech company, in a variety of financial management positions, most recently as Controller of the Connectivity Business Unit, which manufactures and markets adapters and wireless products. Ms. Hu began her career at Deloitte Haskins and Sells. She holds a Bachelor of Music degree from College of Notre Dame and an MBA from California State University, Hayward. She is also a Certified Public Accountant in the state of California.

 

Sherree Lucas
Vice President of Marketing

Sherree Lucas was appointed Vice President of Marketing at Thermage, Inc. on March 1, 2005. With nearly 15 years of marketing experience in B2B and B2C driven companies, she will focus on expanding the well-established Thermage brand among current and prospective customers and growing consumer awareness of its products. Prior to joining Thermage, Ms. Lucas was Marketing Director of Ocular Sciences, Inc. As a senior member of the marketing team at Ocular Sciences, she managed the $100 million U.S. contact lens business that represented one-third of the company's total revenue. During her time at Ocular Sciences, Inc. Ms. Lucas spearheaded the successful turnaround of the Biomedics brand. Prior to Ocular Sciences, she held marketing management roles of escalating responsibility at Oral-B Laboratories, a Gillette Company. At Oral-B, she was responsible for the U.S. launch and international rollout of CrossAction, Oral-B's premiere toothbrush line. Before this role, she also held a variety of management level positions with Sterling Design and Great American Broadcasting Company. Ms. Lucas holds a Bachelor of Business Administration degree from Marshall University and an MBA from New York University.

 

Dragan D. Nebrigic, Ph.D.
Vice President of Research & Development

Dr. Dragan Nebrigic was appointed Vice President of Research and Development on June 25, 2008. Dr. Nebrigic joined Thermage in August 2007 as Senior Director, Advanced Technologies. He brings more than 20 years of experience in Medical Devices as well as Biotechnologies. He holds over 20 US and International Patents in the area of Medical Devices, consumer electronics and medical sensor technologies. Prior to working at Thermage, Dr. Nebrigic served as Senior Director, Global Advanced Technologies and Intellectual Property with Maxwell Technologies and as Executive Director, Engineering and Advanced Technologies with the American Technology Corporation and Molecular Reflections Corporation. During his tenure with Procter and Gamble, from 1996 until 2000, Dr. Nebrigic spearheaded efforts related to novel portable energy sources as well as new consumer biosensor applications, skin parameter detection and measurement devices. He also holds an adjunct Professor position of Electrical Engineering with the University of Cincinnati. Dr. Nebrigic holds a B.S. in Electrical and Computer Engineering and Technical Physics from the University of Belgrade, Serbia, and a Ph.D. in Electrical and Computer Engineering from the University of Cincinnati. He is on the Board of Directors for the Civic Youth Orchestra, San Diego.

 

Sharon Thompson
Vice President of Quality and Regulatory Affairs

Sharon Thompson joined Thermage in January 2008 as Vice President of Quality and Regulatory Affairs and brings 25 years experience in the medical device industry. Most recently, Ms. Thompson was the World Wide Executive Director of Regulatory Affairs at LifeScan, Inc., a diabetes management company. Prior to LifeScan, she was the Executive Director of Quality and Regulatory Compliance for Biosense Webster, a developer and manufacturer of electrophysiology diagnostic and therapeutic devices. Both LifeScan and Biosense Webster are Johnson & Johnson operating companies. Ms. Thompson was previously Vice President of Quality, Regulatory and Clinical Affairs at certain Sorin Group companies; Sorin Biomedical, Inc. and COBE Cardiovascular, Inc. The Sorin Group is based in Milan, Italy. Both companies design and manufacture open heart surgery products. Ms. Thompson began her medical industry career in 1983 at McGaw, Inc, a former division of American Hospital Supply and held technical and managerial positions in Chemistry, Regulatory and at the Biological Test Center (BTC), managing device and pharmaceutical toxicology studies. Ms. Thompson is a former President of the Orange County Regulatory Affairs Discussion Group (a non profit educational organization based in Southern CA) and was on the Board of Directors for three years. She obtained her B.S. degree in Biology/Pre-Med at the State University of New York @ Albany and continued her graduate studies at St. Andrews University in Scotland.

 

Gary L. Wilson
Vice President of International Sales

Gary Wilson joined Thermage, Inc. in 2003 and brings more than 23 years of medical equipment and device experience in worldwide sales, marketing and product development. Most recently, Mr. Wilson was Vice President, Worldwide Sales and Marketing for Cardima, Inc., a manufacturer of minimally-invasive microcatheters for RF ablation of cardiac arrhythmias. Prior to that he was also Vice President, Worldwide Sales and Marketing for EndoSonics Corporation, a manufacturer of diagnostic and therapeutic devices for coronary artery disease. Mr. Wilson was Director, Asia Pacific Sales for Advanced Technology Laboratories (ATL) a manufacturer of diagnostic medical ultrasound imaging equipment. He began his medical industry career with General Electric Medical Systems Division where he held positions in Engineering and Marketing. Mr. Wilson received a BS in Electrical Engineering from the University of California, Santa Barbara and an MBA in International Business from National University.